Expect the Unexpected: SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes and/or Heart Failure. [electronic resource]
- Cardiology 2020
- 321-323 p. digital
Publication Type: Journal Article; Comment
1421-9751
10.1159/000506731 doi
Diabetes Mellitus, Type 2 Dipeptidyl-Peptidase IV Inhibitors Heart Failure Humans Hypoglycemic Agents Sodium-Glucose Transporter 2 Inhibitors